Optimal Pharmacological Therapy In Implantable Defibrillator Patients (OPTIC)

• Status: Completed
• Trial end date: 2004-10-01
• Target enrollment: 0
• Participant gender: All

Summary

This is an open parallel design randomized trial of amiodarone plus a beta blocker vs a beta blocker alone vs sotalol for the prevention of ICD shocks in patients receiving an ICD for spontaneous or inducible ventricular tachycardia or fibrillation

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Connolly, Stuart, M.D.
• Collaborators: Abbott Medical Devices; St. Jude Medical
• Treatments: Adrenergic beta-Antagonists; Amiodarone; Sotalol

Criteria

Inclusion Criteria: spontaneous or inducible ventricular tachycardia or fibrillation -

Exclusion Criteria:

-